Genetic variants modify the associations of concentrations of methylmalonic acid, vitamin B-12, vitamin B-6, and folate with bone mineral density.

BACKGROUND Elevated plasma homocysteine has been found to be associated with an increased risk of osteoporosis, especially hip and vertebral fractures. The plasma concentration of homocysteine is dependent on the activities of several B vitamin-dependent enzymes, such as methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and cystathionine β-synthase (CBS). OBJECTIVES We investigated whether genetic variants in some of the genes involved in 1 carbon metabolism modify the association of B vitamin-related measures with bone mineral density (BMD) and strength. METHODS We measured several B vitamins and biomarkers in participants of the Framingham Offspring Study, and performed analyses of methylmalonic acid (MMA) continuously and <210 nmol/L; pyridoxal-5'-phosphate; vitamin B-12 continuously and ≥258 pmol/L; and folate. The outcomes of interest included areal and volumetric BMD, measured by DXA and quantitative computed tomography (QCT), respectively. We evaluated associations between the bone measures and interactions of single nucleotide polymorphism with a B vitamin or biomarker in Framingham participants (n = 4310 for DXA and n = 3127 for QCT). For analysis of DXA, we validated the association results in the B-PROOF cohort (n = 1072). Bonferroni-corrected locus-wide significant thresholds were defined to account for multiple testing. RESULTS The interactions between rs2274976 and vitamin B-12 and rs34671784 and MMA <210 nmol/L were associated with lumbar spine BMD, and the interaction between rs6586281 and vitamin B-12 ≥258 pmol/L was associated with femoral neck BMD. For QCT-derived traits, 62 interactions between genetic variants and B vitamins and biomarkers were identified. CONCLUSIONS Some genetic variants in the 1-carbon methylation pathway modify the association of B vitamin and biomarker concentrations with bone density and strength.  These interactions require further replication and functional validation for a mechanistic understanding of the role of the 1-carbon metabolism pathway on BMD and risks of fracture.

[1]  D. Kiel,et al.  Dietary protein is associated with musculoskeletal health independently of dietary pattern: the Framingham Third Generation Study. , 2017, The American journal of clinical nutrition.

[2]  D. Kiel,et al.  Novel Genetic Variants Associated With Increased Vertebral Volumetric BMD, Reduced Vertebral Fracture Risk, and Increased Expression of SLC1A3 and EPHB2 , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  I. Choi,et al.  Dietary folate, one-carbon metabolism-related genes, and gastric cancer risk in Korea. , 2016, Molecular nutrition & food research.

[4]  A. Uitterlinden,et al.  Effect of Vitamin B12 and Folic Acid Supplementation on Bone Mineral Density and Quantitative Ultrasound Parameters in Older People with an Elevated Plasma Homocysteine Level: B-PROOF, a Randomized Controlled Trial , 2015, Calcified Tissue International.

[5]  A. Uitterlinden,et al.  Effect of daily vitamin B-12 and folic acid supplementation on fracture incidence in elderly individuals with an elevated plasma homocysteine concentration: B-PROOF, a randomized controlled trial. , 2014, The American journal of clinical nutrition.

[6]  M. Bieda,et al.  Mutation in Folate Metabolism Causes Epigenetic Instability and Transgenerational Effects on Development , 2013, Cell.

[7]  D. Kiel,et al.  Assessment of gene‐by‐sex interaction effect on bone mineral density , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  D. Kiel,et al.  QCT measures of bone strength at the thoracic and lumbar spine: The Framingham study , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  A. Uitterlinden,et al.  Rationale and design of the B-PROOF study, a randomized controlled trial on the effect of supplemental intake of vitamin B12 and folic acid on fracture incidence , 2011, BMC geriatrics.

[10]  A. Morris,et al.  Data quality control in genetic case-control association studies , 2010, Nature Protocols.

[11]  Marcia M. Nizzari,et al.  Candidate Gene Association Resource (CARe)Clinical Perspective , 2010 .

[12]  R. Vasan,et al.  Patterns of Abdominal Fat Distribution , 2009, Diabetes Care.

[13]  H. Lakso,et al.  Quantification of methylmalonic acid in human plasma with hydrophilic interaction liquid chromatography separation and mass spectrometric detection. , 2008, Clinical chemistry.

[14]  Qiong Yang,et al.  The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. , 2007, American journal of epidemiology.

[15]  W. Fraser,et al.  The association of homocysteine and its determinants MTHFR genotype, folate, vitamin B12 and vitamin B6 with bone mineral density in postmenopausal British women. , 2007, Bone.

[16]  Xiping Xu,et al.  Association of the methylenetetrahydrofolate reductase C677T polymorphism and fracture risk in Chinese postmenopausal women. , 2007, Bone.

[17]  Vilmundur Gudnason,et al.  Increasing sex difference in bone strength in old age: The Age, Gene/Environment Susceptibility-Reykjavik study (AGES-REYKJAVIK). , 2006, Bone.

[18]  I. Brandslund,et al.  Analysis of methylmalonic acid in plasma by liquid chromatography-tandem mass spectrometry. , 2006, Clinical chemistry.

[19]  S. Vollset,et al.  Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study. , 2006, Archives of internal medicine.

[20]  D. Cucinotta,et al.  Folate, but not homocysteine, predicts the risk of fracture in elderly persons. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[21]  J. Li,et al.  Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix , 2005, Heredity.

[22]  G. Omrani,et al.  Association of red blood cell 5-methyltetrahydrfoate folate with bone mineral density in postmenopausal Iranian women , 2005, Osteoporosis International.

[23]  P. Jacques,et al.  Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans. , 2005, Bone.

[24]  S. Achenbach,et al.  Calcium Concentration of Individual Coronary Calcified Plaques as Measured by Multidetector Row Computed Tomography , 2005, Circulation.

[25]  P. Lips,et al.  Homocysteine and Vitamin B12 Status Relate to Bone Turnover Markers, Broadband Ultrasound Attenuation, and Fractures in Healthy Elderly People , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  D. Kiel,et al.  Low Plasma Vitamin B12 Is Associated With Lower BMD: The Framingham Osteoporosis Study , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  W. Endres,et al.  A new enzymatic method for pyridoxal-5-phosphate determination , 1981, Journal of Inherited Metabolic Disease.

[28]  W. Herrmann,et al.  Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and post-menopausal women , 2005, Clinical chemistry and laboratory medicine.

[29]  L. Gustafson,et al.  Plasma homocysteine and markers of bone metabolism in psychogeriatric patients. , 2005, Scandinavian journal of clinical and laboratory investigation.

[30]  S. Caudill,et al.  Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. , 2005, The American journal of clinical nutrition.

[31]  D. Levy,et al.  Genomewide linkage analysis to serum creatinine, GFR, and creatinine clearance in a community-based population: the Framingham Heart Study. , 2004, Journal of the American Society of Nephrology : JASN.

[32]  G. Omrani,et al.  Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: a cross-sectional study. , 2004, Bone.

[33]  H. Genant,et al.  Cortical and Trabecular Bone Mineral Loss From the Spine and Hip in Long‐Duration Spaceflight , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  L. Raisz.  Homocysteine and osteoporotic fractures--culprit or bystander? , 2004, The New England journal of medicine.

[35]  A. Hofman,et al.  Homocysteine levels and the risk of osteoporotic fracture. , 2004, The New England journal of medicine.

[36]  D. Kiel,et al.  Homocysteine as a predictive factor for hip fracture in older persons. , 2004, The New England journal of medicine.

[37]  J. Little,et al.  Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. , 2004, American journal of epidemiology.

[38]  D. Kiel,et al.  Association of a Common Polymorphism in the Methylenetetrahydrofolate Reductase (MTHFR) Gene With Bone Phenotypes Depends on Plasma Folate Status , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[39]  L. Christiansen,et al.  Evidence for an association of methylene tetrahydrofolate reductase polymorphism C677T and an increased risk of fractures: results from a population-based Danish twin study , 2004, Osteoporosis International.

[40]  I. Fermo,et al.  Gene-Gene and Gene-Environment Interactions in Mild Hyperhomocysteinemia , 2003, Pathophysiology of Haemostasis and Thrombosis.

[41]  A. Cagnacci,et al.  Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women. , 2003, Bone.

[42]  L. Mosekilde,et al.  A Common Methylenetetrahydrofolate Reductase (C677T) Polymorphism Is Associated With Low Bone Mineral Density and Increased Fracture Incidence After Menopause: Longitudinal Data From the Danish Osteoporosis Prevention Study , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[43]  R. Dhonukshe-Rutten,et al.  Vitamin B-12 status is associated with bone mineral content and bone mineral density in frail elderly women but not in men. , 2003, The Journal of nutrition.

[44]  E. Gunter,et al.  Hyperhomocysteinemia and vitamin B-12 deficiency in elderly using Title IIIc nutrition services. , 2003, The American journal of clinical nutrition.

[45]  B. Abrahamsen,et al.  Association of a Common Allelic Polymorphism (C677T) in the Methylene Tetrahydrofolate Reductase Gene with a Reduced Risk of Osteoporotic Fractures. A Case Control Study in Danish Postmenopausal Women , 2002, Calcified Tissue International.

[46]  T. Keaveny,et al.  Quantitative computed tomography estimates of the mechanical properties of human vertebral trabecular bone , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[47]  G. Abecasis,et al.  Merlin—rapid analysis of dense genetic maps using sparse gene flow trees , 2002, Nature Genetics.

[48]  Y. Ouchi,et al.  Association of Methylenetetrahydrofolate Reductase (MTHFR) Polymorphism with Bone Mineral Density in Postmenopausal Japanese Women , 2000, Calcified Tissue International.

[49]  S. Vollset,et al.  Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. , 1998, The American journal of clinical nutrition.

[50]  C. Frost,et al.  Variability and determinants of total homocysteine concentrations in plasma in an elderly population. , 1998, Clinical chemistry.

[51]  P. Wilson,et al.  Prevalence of cobalamin deficiency in the Framingham elderly population. , 1994, The American journal of clinical nutrition.

[52]  P. Wilson,et al.  Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. , 1993, JAMA.

[53]  W. Browner,et al.  Homocyst(e)inaemia and bone density in elderly women , 1991, The Lancet.

[54]  Thomas M. Cover,et al.  Elements of Information Theory , 2005 .

[55]  K. Pettigrew,et al.  The natural history of homocystinuria due to cystathionine beta-synthase deficiency. , 1985, American journal of human genetics.

[56]  A. Grieco.  Homocystinuria: pathogenetic mechanisms. , 1977, The American journal of the medical sciences.

[57]  W. Kannel,et al.  The Framingham Offspring Study. Design and preliminary data. , 1975, Preventive medicine.

[58]  J. Dorst,et al.  The roentgenographic features of homocystinuria. , 1968, Radiology.

[59]  T. Dawber,et al.  Epidemiological approaches to heart disease: the Framingham Study. , 1951, American journal of public health and the nation's health.